# Safety, PK, and PD Comparison of UI059 and UIC202201 in Healthy Volunteers

> **NCT07727629** · PHASE1 · NOT_YET_RECRUITING · sponsor: **Korea United Pharm. Inc.** · enrollment: 60 (estimated)

## Conditions studied

- Gastro Esophageal Reflux Disorder

## Interventions

- **DRUG:** UI059
- **DRUG:** UIC202201

## Key facts

- **NCT ID:** NCT07727629
- **Lead sponsor:** Korea United Pharm. Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-07
- **Primary completion:** 2026-08
- **Final completion:** 2026-08
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2026-07-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07727629

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07727629, "Safety, PK, and PD Comparison of UI059 and UIC202201 in Healthy Volunteers". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07727629. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*